NovaQuest Capital Management
Raleigh, North Carolina, United StatesFounded 2010
NovaQuest Capital Management is a life sciences investment firm based in Raleigh, NC, providing structured product finance and private equity capital to biopharmaceutical and animal health companies. Founded in 2010, the firm has raised over $2.5 billion across multiple asset classes to fund late-stage drug development and healthcare innovation.
Average disclosed round size is $102.5M (across 9 rounds with reported amounts).
Portfolio
8
Fund Size
$1.2B
Top Stage
Unknown
Last 12 Mo
0
Team
Brian Axe
Partner
Michael Bologna
Partner and Chief Investment Officer
Chris Mauney
Vice President
Dean Moore
Controller
Devin Holden
Chief Compliance Officer
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| FFibrogen, Inc | Unknown | $50M | Nov 2022 |
 Targan | Unknown | $35M | Jun 2022 |
| DDermavant Sciences | Unknown | $160M | Jun 2021 |
| MMileutis Ltd. | Unknown | $20M | Oct 2020 |
 Arvelle | Series A | $180M | Feb 2019 |
| Arvelle | Unknown | $207.8M | Jan 2019 |
 Roivant Sciences Ltd. | Growth | $200M | Nov 2018 |
| EEUSA Pharma | Unknown | $50M | Mar 2008 |
| AArvelle Therapeutics | Unknown | — | — |
| MMileutis Ltd. | Unknown | $20M | — |
Top Co-Investors
Andera Partners3 shared
H.I.G. BioHealth Partners3 shared
BRV Capital Management3 shared
F-Prime Capital2 shared
LSP2 shared
RTW Investments, LP1 shared
EQT Life Sciences1 shared
Oval Park Capital1 shared
Mountain Group Partners1 shared
The Goldman Sachs Group, Inc.1 shared
SV Health Investors1 shared
Advent International1 shared
Hercules Capital, Inc.1 shared
Roche Venture Fund1 shared
Last updated: 19 September 2026